Searched for
DRUGMAKER LUPIN
Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...21 Apr, 2026, 08.37 AM IST- Zydus partners with Lupin to co-market generic semaglutide in IndiaZydus Lifesciences and Lupin are joining forces. They will make a generic version of the popular weight-loss and diabetes drug semaglutide ...17 Mar, 2026, 02.23 PM IST
- Lupin clears Mirabegron patent dispute with Astellas in $90 million deal, secures US sales continuityDrugmaker Lupin has settled a patent infringement dispute with Astellas Pharma over its Mirabegron product for $90 million. The agreement i...10 Feb, 2026, 08.44 AM IST
- Sun Pharma, Lupin recall drugs in US market: USFDASun Pharmaceutical is recalling the affected lot that was produced at the drugmaker's Dadra-based facility. The company is recalling the lo...17 Dec, 2023, 10.48 AM IST
- Lupin Q3 Results: Net profit up 24% at Rs 545 crThe Mumbai-based drugmaker had reported a net profit of Rs 438.3 crore in the October-December quarter of the previous fiscal.04 Feb, 2022, 11.46 AM IST
- Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...06 Sep, 2021, 12.53 PM IST
- Lupin gets USFDA nod for generic drugDrugmaker Lupin on Friday said it has received approval from the US health regulator to market Droxidopa capsules, used to treat dizziness....19 Feb, 2021, 05.08 PM IST
- Lupin shuts manufacturing drug plant after 17 employees test positive for Covid-19The company has some 11 manufacturing plants at the Ankleshwar site in Gujarat state, which is spread out over 40 acres and has 984 employe...14 Jul, 2020, 08.44 PM IST
- Lupin remains a ‘sell’ on Q4 miss; Target prices cutCitigroup and Elara have maintained sell rating and Antique has reiterated its hold rating.17 May, 2019, 07.58 AM IST
- Lupin launches generic hypertension drug in USLupin's tablets for treating hypertension, Amlodipine and Valsartan, are the generic version of Novartis's Exforge tablets.01 Apr, 2015, 03.51 PM IST
- Lupin to acquire additional 40% stake in SA's Pharma DynamicsThe move would add an additional global muscle to Pharma Dynamics' operations and support the next phase of growth for the company, he adde...17 Mar, 2015, 04.29 AM IST
- TCS, Lupin rise in CLSA portfolio, State Bank of India outCLSA has tweaked its model portfolio, increasing the weightage of India’s leading software exporter TCS and domestic drugmaker Lupin.14 Sep, 2013, 10.50 AM IST
- Billionaire Jhunjhunwala sells holding worth over Rs 300 cr in Q1Shares of drugmaker Lupin fell after the company disclosed that billionaire investor Rakesh Jhunjhunwala has hal-ved his stake in the compa...21 Jul, 2011, 06.20 AM IST
- Lupin files second suit against RanbaxyMumbai-based drugmaker Lupin has filed a second suit in the US against Ranbaxy Laboratories to prevent the country’s largest drugmaker from...06 Apr, 2011, 05.02 AM IST
- Novo sues Lupin to block generic in USDanish company Novo Nordisk has sued Mumbai-based drugmaker Lupin to prevent it from launching the low priced version of its patented diabe...25 May, 2010, 01.37 AM IST
- Lupin can't sell pill in US, Teva files patent suitIsraeli drugmaker Teva Pharma has filed a patent infringement suit in the US against Lupin that prevents the Indian pharma company from sel...20 Jan, 2010, 03.45 AM IST
- Lupin settles case with WyethLupin has struck an out-of-court settlement with Wyeth relating to the foreign company’s antidepressant ‘Effexor XR’ capsules.12 May, 2009, 04.25 AM IST
Load More
